Intrauterine therapy for structural congenital heart disease: Contemporary results and Canadian experience

Percutaneous, ultrasound-guided fetal cardiac intervention (FCI) is increasingly used to alter the prognosis of specific forms of congenital heart disease. Careful patient selection and postnatal management strategy are essential for optimal outcomes. This article discusses the rationale, patient selection criteria, procedural techniques, and contemporary results of FCI. Sources of information included published patient series, the International Fetal Cardiac Intervention Registry, and the Toronto experience as the Canadian referral center.